logo
ENTITY

NeuroBo Pharmaceuticals (NRBO US)

5
Analysis
Health Care • United States
NeuroBo Pharmaceuticals Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing therapies for the treatment of dyslipidemia. NeuroBo Pharmaceuticals conducts business in the United States.
more
Exchange Announcement • 08 Nov 2024 05:06

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Exchange Announcement • 07 Nov 2024 21:01

Current Report (Form 8-K | Period ending 2024-11-07)

Exchange Announcement • 04 Nov 2024 21:30

Current Report (Form 8-K | Period ending 2024-11-04)

Exchange Announcement • 07 Oct 2024 19:00

Current Report (Form 8-K | Period ending 2024-10-07)

Exchange Announcement • 30 Sep 2024 20:07

Current Report (Form 8-K | Period ending 2024-09-30)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.3

x